The historical rank and industry rank for Kubota Pharmaceutical Holdings Co's FCF Margin % or its related term are showing as below:
TSE:4596'
s FCF Margin % Range Over the Past 10 Years
Min: -25983.41 Med: -4046.93 Max: -379.31
Current: -4627.83
During the past 11 years, the highest FCF Margin % of Kubota Pharmaceutical Holdings Co was -379.31%. The lowest was -25983.41%. And the median was -4046.93%.
TSE:4596's FCF Margin % is ranked worse than 89.47% of 959
companies
in the Biotechnology industry
Industry Median: -84.65
vs TSE:4596: -4627.83
Kubota Pharmaceutical Holdings Co FCF Margin % Related Terms
Kubota Pharmaceutical Holdings Co FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kubota Pharmaceutical Holdings Co FCF Margin % Chart
TSE:4596 vs VRTX, REGN, ALNY: FCF Margin % Comparison
For the Biotechnology subindustry, Kubota Pharmaceutical Holdings Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kubota Pharmaceutical Holdings Co FCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kubota Pharmaceutical Holdings Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Kubota Pharmaceutical Holdings Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kubota Pharmaceutical Holdings Co (TSE:4596) has a FCF Margin % of -6,240.31% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Kubota Pharmaceutical Holdings Co and its competitors. According to the industry distribution chart, Kubota Pharmaceutical Holdings Co ranks #858 out of 959 companies in the Biotechnology industry, placing it in the top 89.5%.
Is Kubota Pharmaceutical Holdings Co's FCF Margin % too high?
Kubota Pharmaceutical Holdings Co's current FCF Margin % is -6,240.31%. Based on the distribution chart, Kubota Pharmaceutical Holdings Co ranks #858 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Kubota Pharmaceutical Holdings Co has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kubota Pharmaceutical Holdings Co's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kubota Pharmaceutical Holdings Co ranks #858 out of 959 companies for FCF Margin %. This places Kubota Pharmaceutical Holdings Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Kubota Pharmaceutical Holdings Co and its competitors. Kubota Pharmaceutical Holdings Co's current FCF Margin % is -6,240.31%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kubota Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co (TSE:4596) is currently considered Significantly Overvalued. The stock's GF Value™ is 円39.87, compared to a current price of 円56.00 — trading 40.5% above its estimated fair value. The current FCF Margin % is -6,240.31%. Kubota Pharmaceutical Holdings Co's overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Kubota Pharmaceutical Holdings Co (TSE:4596), the current FCF Margin % is -6,240.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kubota Pharmaceutical Holdings Co (TSE:4596) Overvalued in 2026?
Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co stock appears to be overvalued.
The current stock price of 円56.00 is trading 40.5% above its estimated GF Value™ of 円39.87.
GuruFocus considers Kubota Pharmaceutical Holdings Co to be Significantly Overvalued.
Key valuation signals for TSE:4596:
FCF Margin %: -6,240.31%
GF Value™: 円39.87 vs. price of 円56.00 (40.5% above fair value)
No single metric tells the full story. See the TSE:4596 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kubota Pharmaceutical Holdings Co Business Description
Kubota Pharmaceutical Holdings Co Ltd is a Japanese company providing portfolio of drugs and devices to preserve and restore millions of people. It identifies and develops therapeutics to treat the opthalmic disorder and operations incidental or related thereto. Its pipeline products include VCM-Emixustat HCI, Lanosterol and Optogenetics.
46GF Score
Get the complete analysis for TSE:4596
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4596 has been successfully added to your 
